CRSP logo

CRISPR Therapeutics AG (CRSP) EV/EBITDA

EV/EBITDA

-8.46
+0.10+1.17%

31 min ago


Summary


Performance

CRSP EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherCRSPvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

CRSP EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+1.2%-1.1%-1.1%
1 m1 month-13.7%+13.7%+13.4%
3 m3 months+37.3%-10.4%-9.1%
6 m6 months+21.9%+4.3%-1.3%
ytdytd-14.8%+14.8%+14.4%
1 y1 year+73.6%-41.8%-43.0%
5 y5 years-123.8%+107.2%+0.7%

CRSP EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-13.7%-10.00+15.4%
3 m3-month-7.20-17.5%-14.25+40.6%
6 m6-month-7.20-17.5%-15.14+44.1%
1 y1-year-7.20-17.5%-32.22+73.7%
3 y3-year15.82-153.5%-36.33+76.7%
5 y5-year2149.62-100.4%-49.83+83.0%
alltimeall time2149.62-100.4%-732.31+98.8%

CRISPR Therapeutics AG EV/EBITDA History

DateValue
2025
-8.46(+14.8%)
2024
-7.37(-69.4%)
2023
-24.05(+371.6%)
2022
-5.10(-138.9%)
2021
13.12(-144.4%)
DateValue
2020
-29.57(-154.1%)
2019
54.62(-928.8%)
2018
-6.59(-43.1%)
2017
-11.58(-67.5%)
2016
-35.60

FAQ

  • What is CRISPR Therapeutics AG EV/EBITDA?
  • What is the all time high EV/EBITDA for CRISPR Therapeutics AG?
  • What is CRSP EV/EBITDA year-to-date change?
  • What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?

What is CRISPR Therapeutics AG EV/EBITDA?

The current EV/EBITDA of CRSP is -8.46

What is the all time high EV/EBITDA for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high EV/EBITDA is 2149.62

What is CRSP EV/EBITDA year-to-date change?

CRISPR Therapeutics AG EV/EBITDA has changed by -1.09 (-14.79%) since the beginning of the year

What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?

Over the past year, CRSP EV/EBITDA has changed by +23.60 (+73.61%)